Discovery and characterization of a covalent inhibitor of New Delhi metallo β-lactamase
Archives of Biochemistry and Biophysics · 2026-07 · 781 · 110805
DOI: 10.1016/j.abb.2026.110805 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives of Biochemistry and Biophysics, 2026-07. Verfasst von Dann D Rivera und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Chemical Biology and Medicinal Chemistry, College of Pharmacy, University of Texas at Austin, Austin, TX, 78712, United States. Hauptthemen laut MEDLINE: beta-Lactamases, beta-Lactamase Inhibitors, Acrylamide. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, National Institutes of Health Center for Scientific Review, National Institutes of Health.
Abstract (Originalsprache)
New Delhi metallo β-lactamase (NDM-1) grants bacteria resistance to a broad spectrum of β-lactam antibiotics, including the last resort carbapenems. The absence of a nucleophilic serine in the active site of NDM-1 renders it resistant to canonical β-lactamase inhibitors that are used to treat β-lactam resistant bacteria. Herein, we report two new covalent irreversible inhibitors that target two highly conserved nucleophilic residues in the active site of NDM-1. N-Acryloyl-N-(isoquinoline-1-yl)acrylamide (2) inhibits NDM-1 in a time- and concentration-dependent manner without showing saturation kinetics (kinact/KI value = 4.6 ± 0.1 M-1s-1). Site-directed mutagenesis and ultraviolet photodissociation (UVPD) mass spectrometry reveal modification of the highly conserved active-site lysine (Lys211). The absence of saturation kinetics and incomplete inactivation of substrate turnover prompted the development of N-(8-hydroxyquinolin-2-yl)acrylamide (6), which appends a different metal binding motif to the acrylamide electrophile. Compound 6 also inhibits NDM-1 in a time- and concentration-dependent manner and shows saturation kinetics (KI = 167 ± 40 μM, kinact = 0.12 ± 0.01 min-1, kinact/KI = 12.0 ± 3.0 M-1s-1). Site-directed mutagenesis and UVPD mass spectrometry reveal modification of the zinc-coordinating active-site cysteine (Cys208). These results suggest that acrylamide can be used as an electrophilic warhead for targeting nucleophilic residues in the active site of NDM-1. Moreover, these inhibitors are promising scaffolds from which to design a covalent inhibitor that can serve as a codrug to restore the efficacy of β-lactams when treating NDM-1 expressing bacteria.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Chemical Biology and Medicinal Chemistry, College of Pharmacy, University of Texas at Austin, Austin, TX, 78712, United States.
- Department of Chemistry, The University of Texas at Austin, Austin, TX, 78712, United States.
- Division of Chemical Biology and Medicinal Chemistry, College of Pharmacy, University of Texas at Austin, Austin, TX, 78712, United States. Electronic address: whitman@austin.utexas.edu.
Förderung
- NIGMS NIH HHS
- National Institutes of Health Center for Scientific Review
- National Institutes of Health
- The Welch Foundation
Zitieren
APA
Rivera, D. D., Schroeder, J. M., Walker, J. N., Bashyal, A., Iyer, A. G., Lee, R. H., Melkonian, T. R., Brodbelt, J. S., Fast, W., & Whitman, C. P. (2026). Discovery and characterization of a covalent inhibitor of New Delhi metallo β-lactamase. Archives of Biochemistry and Biophysics, 781, 110805. https://doi.org/10.1016/j.abb.2026.110805
Vancouver
Rivera DD, Schroeder JM, Walker JN, Bashyal A, Iyer AG, Lee RH, et al. Discovery and characterization of a covalent inhibitor of New Delhi metallo β-lactamase. Archives of Biochemistry and Biophysics. 2026;781:110805. doi:10.1016/j.abb.2026.110805
BibTeX
@article{Rivera2026,
author = {Rivera, Dann D and Schroeder, John M and Walker, Jada N and Bashyal, Aarti and Iyer, Ayush G and Lee, Ryan H and Melkonian, Trevor R and Brodbelt, Jennifer S and Fast, Walter and Whitman, Christian P},
title = {Discovery and characterization of a covalent inhibitor of New Delhi metallo β-lactamase},
journal = {Archives of Biochemistry and Biophysics},
year = {2026},
volume = {781},
pages = {110805},
doi = {10.1016/j.abb.2026.110805}
}
EUVIMED